News tagged with abbott laboratories
Palivizumab cuts number of days of wheezing in preemies
(HealthDay)—Many pre-term babies suffer recurrent episodes of wheezing. Now, researchers say a common infection is a likely culprit and they may be able to prevent the breathing problems.
Diseases, Conditions, Syndromes
May 09, 2013 |
not rated yet |
0
|
Abbott Laboratories recalls blood glucose meters
Abbott Laboratories is recalling its FreeStyle InsuLinx Blood Glucose Meters after finding that they display and store incorrect test results for dangerously high blood sugar levels.
Medications
Apr 15, 2013 |
not rated yet |
0
Adalimumab relieves hidradenitis suppurativa
(HealthDay)—For patients with moderate-to-severe hidradenitis suppurativa (HS), a chronic skin disease characterized by painful abscesses, nodules, and draining fistulas in the axilla and groin, treatment ...
Inflammatory disorders
Dec 18, 2012 |
not rated yet |
0
Fenofibrate / simvastatin benefit in dyslipidemia explored
(HealthDay)—Combination treatment with fenofibrate and simvastatin (FENO-S) significantly reduces postprandial (PP) triglyceride (TG) levels compared with simvastatin alone in all subjects, regardless of ...
Diabetes
Nov 01, 2012 |
4.5 / 5 (2) |
0
New HIV test for infants seen as possible breakthrough for sub-Saharan Africa
In HIV-plagued sub-Saharan Africa, it can take up to three months for mothers to learn whether their babies have been infected by the deadly virus, delaying what could be life-sustaining treatment.
HIV & AIDS
Oct 26, 2012 |
not rated yet |
0
Abbott Labs rises on hepatitis C drug data (Update)
Abbott Laboratories said Monday that its experimental hepatitis C drug regimen cured 99 percent of patients in a midstage study with the most common and hardest-to-treat type of the disease.
Medications
Oct 15, 2012 |
not rated yet |
0
Humira's approval widened to include ulcerative colitis
(HealthDay)—Humira (adalimumab) has been approved by the U.S. Food and Drug Administration to treat moderate-to-severe ulcerative colitis in adults, the agency said Friday.
Medications
Oct 01, 2012 |
not rated yet |
0
BRCA1 or BRCA2 mutation research may offer treatment option to certain patients
(Medical Xpress)—Ongoing research at the Methodist Cancer Center could reveal whether metastatic breast cancer patients with BRCA gene mutations are particularly responsive to a drug regimen that includes Veliparib, an ...
Cancer
Sep 20, 2012 |
not rated yet |
0
FDA approves new test for Chagas disease
The Food and Drug Administration has approved Abbott Laboratories' ESA test for Chagas disease, which could be a useful tool in protecting the nation's blood supply from contamination.
Diseases, Conditions, Syndromes
Nov 26, 2011 |
not rated yet |
0
